Alex Goldsmith joined Flagship Pioneering in 2017. He works closely with Noubar Afeyan, the firm’s CEO, providing insights and recommendations on questions of science and technology and helping Flagship to deliver on its unique innovation strategy.
Alex joined Flagship from Pfizer, where he served in several positions within the company’s Worldwide R&D organization. Most recently, he was head of business operations and strategy for the Medicinal Sciences division, a large and complex unit responsible for the design, development, and early manufacturing of small molecules, biologics, and vaccines. Immediately before joining Pfizer, Alex worked at The Boston Consulting Group, where he advised clients on strategic and operational issues across a range of industries.
Alex holds a Ph.D. in neurobiology from the University of Cambridge and an undergraduate degree (First Class Honours) in molecular and cellular biochemistry from Oxford University.